These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4104013)

  • 21. [Prophylaxis of human rabies].
    Del Vecchio V; D'Arca Simonetti A; D'Arca SU; Zardi O
    G Mal Infett Parassit; 1967 Nov; 19(11):775-814. PubMed ID: 5615746
    [No Abstract]   [Full Text] [Related]  

  • 22. Seroneutralization and splenoneutralization tests in the course of rats rabies caused by the short time incubation strain.
    Wojciechowski K
    Acta Microbiol Pol B; 1971; 3(3):167-70. PubMed ID: 4940212
    [No Abstract]   [Full Text] [Related]  

  • 23. [Light microscopic localization of rabies virus antigen by means of peroxidase-labeled immunoglobulin (On the usefulness of immunoenzyme technique)].
    Jentzsch KD; Zipper J
    Exp Pathol (Jena); 1974; 9(3):163-8. PubMed ID: 4140099
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serological study on subjects vaccinated with Hempton's vaccine. II].
    Doutlík S; Jezková Z; Vacek Z; Sixtová E
    Cas Lek Cesk; 1970 Mar; 109(13):261-5. PubMed ID: 5462090
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the immunogenicity of antigen-antibody precipitates. II. The suppressive effect of anti-carrier and anti-hapten antibodies on the immunogenicity of dinitrophenylated human gamma G globulin.
    Henney CS; Ishizaka K
    J Immunol; 1970 Jun; 104(6):1540-9. PubMed ID: 4195052
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rabies. Virology, immunology and prevention].
    Haas R
    Z Allgemeinmed; 1971 Sep; 47(25):1265-70. PubMed ID: 5110500
    [No Abstract]   [Full Text] [Related]  

  • 27. [Normal production of antibodies against the Semple type of anti-rabies vaccine in persons treated with paramethasone].
    Campillo Sainz C; López Pintado F; Núñez Rivera A
    Rev Invest Salud Publica; 1966; 26(3):193-200. PubMed ID: 5993038
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect on immunity to challenge and antibody response of variation in dosage schedule of rabies vaccine in mice.
    HABEL K
    Bull World Health Organ; 1956; 14(4):613-6. PubMed ID: 13356138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the plaque assay technique to the study of rabies virus-neutralizing antibody interactions.
    Wiktor TJ; Clark HF
    Ann Microbiol (Paris); 1973 Mar; 124(2):271-82. PubMed ID: 4127063
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonfatal canine rabies.
    Arko RJ; Schneider LG; Baer GM
    Am J Vet Res; 1973 Jul; 34(7):937-8. PubMed ID: 4720680
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of human rabies immune globulin and homologous and heterologous antibody.
    Winkler WG; Schmidt RC; Sikes RK
    J Immunol; 1969 May; 102(5):1314-21. PubMed ID: 4181550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some aspects of interference in passive-active rabies immunization].
    Lisianyĭ NI
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):71-5. PubMed ID: 4109020
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses.
    Brookes SM; Parsons G; Johnson N; McElhinney LM; Fooks AR
    Vaccine; 2005 Jul; 23(32):4101-9. PubMed ID: 15964478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunologic prevention of rabies. III. Experimental evaluation of the capacity of an antigen of a vaccine obtained from the brain of suckling mice].
    Vescia N; Mastroeni I; Simonetti AD; D'arca SU; Tarsitani G
    Nuovi Ann Ig Microbiol; 1974; 25(5):307-18. PubMed ID: 4465765
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Demonstration of rabies virus in immunized mice and dogs after experimental infection].
    Marcus I; Harasim E; Bieniek HJ
    Dtsch Tierarztl Wochenschr; 1971 Jun; 78(11):320-5. PubMed ID: 4930874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.